BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 208 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,890 | -3.4% | 267 | -4.0% | 0.00% | – |
| Q2 2023 | $1,957 | -16.2% | 278 | -0.7% | 0.00% | – |
| Q1 2023 | $2,335 | -23.5% | 280 | +5.3% | 0.00% | – |
| Q4 2022 | $3,054 | +1.8% | 266 | +2.7% | 0.00% | – |
| Q3 2022 | $3,000 | 0.0% | 259 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -89.7% | 259 | -85.3% | 0.00% | -100.0% |
| Q1 2022 | $29,000 | +20.8% | 1,759 | 0.0% | 0.00% | +100.0% |
| Q4 2021 | $24,000 | -4.0% | 1,759 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $25,000 | -10.7% | 1,759 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $28,000 | +55.6% | 1,759 | 0.0% | 0.00% | +100.0% |
| Q1 2021 | $18,000 | +63.6% | 1,759 | +17.3% | 0.00% | 0.0% |
| Q4 2020 | $11,000 | +1000.0% | 1,500 | +200.0% | 0.00% | – |
| Q3 2019 | $1,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
| Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
| DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
| Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
| Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
| Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
| KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
| Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |